Early Tumour Shrinkage: A Tool for the Detection of Early Clinical Activity in Metastatic Renal Cell Carcinoma

Volume: 70, Issue: 6, Pages: 1006 - 1015
Published: Dec 1, 2016
Abstract
The predictive role of objective remission remains undefined for targeted agents in metastatic renal cell carcinoma (mRCC); however, early tumour shrinkage (eTS) was shown to be predictive and/or prognostic for overall survival (OS) and progression-free survival (PFS) in mRCC in several small studies. To evaluate the degree of eTS following systemic therapy that may predict survival in mRCC. Data from 4334 patients with mRCC in phase 2 and 3...
Paper Details
Title
Early Tumour Shrinkage: A Tool for the Detection of Early Clinical Activity in Metastatic Renal Cell Carcinoma
Published Date
Dec 1, 2016
Volume
70
Issue
6
Pages
1006 - 1015
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.